
Company valuation, historical trends, and peer comparisons.
According to Inhibrx Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 930.12M. This represents a change of -2.86% compared to the average of 957.53M of the last 4 quarters.
The mean historical Enterprise Value of Inhibrx Biosciences Inc. over the last ten years is 897.01M. The current 930.12M Enterprise Value has changed 3.69% with respect to the historical average. Over the past ten years (40 quarters), INBX's Enterprise Value was at its highest in in the December 2023 quarter at 1.99B. The Enterprise Value was at its lowest in in the June 2024 quarter at -23823940.00.
Average
897.01M
Median
768.66M
Minimum
78.38M
Maximum
1.72B
Discovering the peaks and valleys of Inhibrx Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.44%
Maximum Annual Enterprise Value = 1.72B
Minimum Annual Increase = -95.45%
Minimum Annual Enterprise Value = 78.38M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.21B | 1.44% |
| 2024 | 78.38M | -95.45% |
| 2023 | 1.72B | 87.00% |
| 2022 | 921.50M | -42.43% |
| 2021 | 1.60B | 115.84% |
| 2020 | 741.65M | -5.44% |
| 2019 | 784.31M | 38.57% |
| 2018 | 565.99M | -4.89% |
| 2017 | 595.11M | -20.97% |
The current Enterprise Value of Inhibrx Biosciences Inc. (INBX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
1.00B
5-year avg
1.11B
10-year avg
897.01M
Inhibrx Biosciences Inc.’s Enterprise Value is less than Generate Biomedicines, Inc. (1.68B), less than Janux Therapeutics, Inc. (1.06B), greater than Tectonic Therapeutic, Inc. (140.87M), less than Celldex Therapeutics, Inc. (2.21B), greater than Immatics N.V. (733.89M), less than Absci Corporation (1.69B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.68B | $1.75B | |
| 1.06B | $1.07B | |
| 140.87M | $363.54M | |
| 2.21B | $2.25B | |
| 733.89M | $1.07B | |
| 1.69B | $1.79B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inhibrx Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inhibrx Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Inhibrx Biosciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Inhibrx Biosciences Inc. (INBX)?
What is the 3-year average Enterprise Value for Inhibrx Biosciences Inc. (INBX)?
What is the 5-year average Enterprise Value for Inhibrx Biosciences Inc. (INBX)?
How does the current Enterprise Value for Inhibrx Biosciences Inc. (INBX) compare to its historical average?